Total Cycles
138
Reported 2022
Medical Disclaimer: This data is for informational purposes only. Success rates are influenced by patient age, diagnosis, and treatment type. Do not use this data alone to choose a fertility clinic. Consult a board-certified reproductive endocrinologist.
CDC NASS 2022 138 ART cycles Louisiana
ArkLaTex Fertility and Reproductive Medicine
ArkLaTex Fertility and Reproductive Medicine reported a 53.5% overall live-birth rate across 138 ART cycles in Shreveport, Louisiana (CDC NASS 2022).
Clinic verdict · CDC NASS 2022
ArkLaTex Fertility and Reproductive Medicine's IVF live-birth rate for patients under 35 is 53.5%, 6 points above the national average of 48%. Compare it across age groups and against the state below, and remember age is the strongest driver of IVF success.
53.5% Overall live birth
53.5% Under 35
138 Cycles, 2022
48% National, under 35
Where ArkLaTex Fertility and Reproductive Medicine sits among U.S. clinics
Overall CDC live-birth-rate band, 406 reporting clinics
This clinic
Overall Success Rate
53.5%
Live births per cycle
+13.1pp vs LA avg
Rate Under 35
53.5%
Peak fertility cohort
Single Embryo Transfer
41.9%
ASRM-aligned safety metric
SET adherence vs national reference
Single-embryo-transfer rate is an ASRM-aligned safety metric, higher SET reduces multi-pregnancy and OHSS risk.
ArkLaTex Fertility and Reproductive Medicine SET rate 41.9%
78% national reference
Share of transfers using one embryo only
Success Rates by Age Group
Using own eggs (fresh + frozen cycles). The CDC reports patients over 40 in two separate brackets, 41–42 and 43+, shown here individually rather than combined.
Under 35 53.5%
35–37 Not reported
38–40 Not reported
41–42 Not reported
43+ Not reported
Success rate = live births per ART cycle started. Source: CDC NASS 2022.
Cycle Breakdown
- Total Cycles
- 138
- Fresh Cycles
- 50
- Frozen Cycles
- 88
- Years Reporting
- 3
- Single Embryo Transfer %
- 41.9%
Services Available
- ✓ Donor Egg Available
- ✓ Gestational Carrier
What the CDC NASS Data Shows for ArkLaTex Fertility and Reproductive Medicine
ArkLaTex Fertility and Reproductive Medicine reported cycle outcomes to the CDC National ART Surveillance System for the 2022 reporting year, with 3 years of cumulative reporting history. The clinic performed 138 total ART cycles, split between 50 fresh and 88 frozen embryo transfer cycles. The overall success rate, live births per cycle started, was 53.5%. That is 13.1 percentage points above the Louisiana state average of 40.4%.
Age remains the dominant variable in IVF outcomes. At ArkLaTex Fertility and Reproductive Medicine, patients under 35 saw a 53.5% success rate. Single embryo transfer (SET) was used in 41.9% of cycles, a metric ASRM associates with lower multi-pregnancy rates.
Service availability also affects which clinics fit which patients. ArkLaTex Fertility and Reproductive Medicine does report donor egg services and does offer gestational carrier (surrogate) cycles. These services matter for patients with diminished ovarian reserve, same-sex couples, or medical conditions that preclude carrying a pregnancy. Every figure above is a public federal disclosure, not editorial commentary, PlainFertility is not affiliated with ArkLaTex Fertility and Reproductive Medicine or the CDC, and these statistics are not a substitute for an evaluation by a board-certified reproductive endocrinologist who can assess your individual diagnosis, history, and treatment options.
Read these figures as a starting point, not a verdict. The CDC reports live births per intended egg retrieval, so the percentages already account for cycles that never reached embryo transfer, a more conservative measure than the per-transfer pregnancy rates clinics sometimes advertise. Group results describe what happened for past patients; they cannot predict an individual outcome, which depends on diagnosis, ovarian reserve, sperm quality, embryo genetics, and the protocol a physician recommends. A single reporting year can swing for lower-volume clinics, so cumulative multi-year results and a candid consultation carry more weight than any one published number.
Historical Success Rates
| Year | Total Cycles | Overall | Under 35 | 35–37 | 38–40 | 41–42 |
|---|---|---|---|---|---|---|
| 2022 | 138 | 53.5% | 53.5% | N/A | N/A | N/A |
| 2021 | 151 | 45.5% | 45.5% | N/A | N/A | N/A |
| 2020 | 105 | N/A | N/A | N/A | N/A | N/A |
Frequently Asked Questions
ArkLaTex Fertility and Reproductive Medicine's IVF success rate
ArkLaTex Fertility and Reproductive Medicine reports an overall IVF success rate of 53.5% across 138 reported cycles. Rates by age group vary, patients under 35 generally see higher success rates.
How should I interpret these success rates?
IVF success rates depend on patient age, diagnosis, embryo type, and treatment protocol. A clinic with a lower success rate may treat more complex cases. Always consult a board-certified reproductive endocrinologist who can evaluate your individual situation.
Where does this data come from?
All data is sourced from the CDC's National ART Surveillance System (NASS), which requires all ART clinics in the US to report their cycle outcomes annually under the Fertility Clinic Success Rate and Certification Act of 1992.
What is the difference between fresh and frozen IVF cycles?
Fresh cycles use embryos that have not been frozen, eggs are retrieved, fertilized, and transferred within the same treatment cycle. Frozen cycles use previously cryopreserved embryos. ArkLaTex Fertility and Reproductive Medicine reported 50 fresh cycles and 88 frozen cycles. Many clinics now favor frozen embryo transfers (FET) due to improved vitrification technology and comparable or higher success rates.
What does single embryo transfer (SET) percentage mean?
Single embryo transfer percentage indicates how often a clinic transfers just one embryo per cycle rather than multiple embryos. A higher SET rate generally reflects adherence to current ASRM guidelines aimed at reducing multiple pregnancies. ArkLaTex Fertility and Reproductive Medicine reports a SET rate of 41.9%. Higher SET rates typically mean fewer twins and triplets, which reduces pregnancy complications.
Does this clinic offer donor egg or gestational carrier services?
ArkLaTex Fertility and Reproductive Medicine does offer donor egg services and does offer gestational carrier (surrogate) services per the latest CDC NASS report. Contact the clinic directly to confirm current service availability and discuss whether these options are appropriate for your treatment plan.
PlainFertility Guides
Data source: CDC National ART Surveillance System (NASS). PlainFertility is not affiliated with the CDC or this clinic.
Read our methodology - how this data is sourced, computed, and verified.
Related
Data sourced from the CDC National ART Surveillance System (NASS). See our methodology for details. Retrieved and formatted by PlainFertility Editorial
Every figure on PlainFertility is rendered directly from CDC National ART Surveillance System source data, no number is typed in by an editor. This page draws directly on CDC National ART Surveillance System source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.